5 Common Myths That Accompany a Cancer Diagnosis
Receiving a cancer diagnosis can be the most terrifying moment of your life. It may feel as though your world is caving in ar [...]
Tempus Partners with Artera to Expand Personalized Prostate Cancer Treatment
Tempus, a leader in using artificial intelligence (AI) to advance precision medicine connected to over half of all practicing [...]
Andre Esteva Named 40 Under 40 by Modern Healthcare
Many of this year’s 40 Under 40 honorees were motivated to pursue a career in healthcare by watching family members navigate [...]
Optimizing Kubernetes Log Aggregation: Tackling Fluent Bit Buffering and Backpressure Challenges
At Artera, we rely on Kubernetes (EKS) clusters to run applications, with Fluent Bit handling log forwarding to DataDog for m [...]
Are Open Source Pathology Foundation Models ready for the clinic?
Imagine that a pathologist reads a slide and diagnoses a patient’s cancer on a Monday. They return a few weeks later, read th [...]
AI significantly improves risk classification for prostate cancer metastasis
An AI model classified risk for prostate cancer metastasis more accurately than standard guidelines, suggesting the approach [...]
Artera’s Multimodal Artificial Intelligence Named Among TIME’s 2024 Best Inventions
Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced th [...]
Investigating AWS and GitHub Actions Runners Network conflict
In modern DevOps workflows, continuous integration and deployment pipelines are critical for maintaining rapid development cy [...]
Artera Receives California Lab License, Expanding Access to its ArteraAI Prostate Test
Clinicians and patients in California can now access personalized, actionable insights to inform prostate cancer treatment de [...]